Hemant Soni

Hemant Soni

Auto-generated profile, based on publicly available information

Hemant Soni

Section of Microbiology, Central Ayurveda Research Institute – Jhansi, Uttar Pradesh, India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2023 in Frontiers in Chemistry
Verified
Journal Article
Open access
VCVaibhav Charde
Vaibhav Charde
VKVijay Kumar
Vijay Kumar
GDGanesh Dane
Ganesh Dane
YGYashika Gandhi
Yashika Gandhi
HSHemant Soni
Hemant Soni
TWThomas Webster
Thomas Webster
Gairika (red ochre) has a long history of influencing human civilization. Gairika is a rich source of nutrients used for reproductive and brain health. Gairika is mentioned as an antacid drug in Indian Ayurvedic medicine under Laghu Sutashekhara Rasa (LSR). However, a detailed study on LSR has not been reported to date. In the present study, LSR was prepared, and a pharmaceutical SOP (standardization procedure) was reported to obtain batch-to-batch reproducibility. LSR was characterized using FTIR, XRD, SEM-EDX, and TGA analyses. LSR was tested in vitro for its antacid activity. Advanced instrumentation revealed that LSR formation produced symmetrical particles (5–8 µm) with kaolin, kaolinite, quartz, goethite, and hematite, along with the phytoconstituents of Goghrita (clarified cow’s butter), Shunthi, and Nagawalli, as confirmed by GC-MS/MS analysis. The FTIR study revealed the formation of a chelating complex of goethite and hematite along with their phytoconstituents. XRD analysis confirmed the presence of kaolin, kaolinite, quartz, goethite, and hematite. Using in vitro antacid experiments, LSR and Shunthi demonstrated significant antacid activity as compared to antacid drugs and standards in the market, such as CaCO3. The DPPH assay revealed IC50 values of 12.16 ± 1.23 mg/mL, which is 0.0029 of Trolox-equivalent antioxidant activity. The inhibition (18 ± 4 mm) against pathogens (S. aureus, E. coli, P. aeruginosa, and B. subtilis) and the prominent growth of gut microbiota-supported strains (S. boulardii, L. paracasei, and L. plantarum) observed on LSR formulation were indicative of LSR application as a prebiotic. Here, the mechanism of purification and levigation mentioned in the classical literature of LSR was established. Overall, purification of Gairika with cow ghee and levigation with Nagawalli may enhance the solubility, bioavailability, and shelf-life of LSR through hydration and co-crystallization mechanisms. This is the first comprehensive report on the pharmaceutical validation of LSR and its characterization. The results of the present study could contribute to the development and reliable reproduction of LSR and the utility of environmental red ochre as a medicine in combination with Shunthi (Zingiber officinale Roxb.), as prescribed under Indian Ayurvedic medicine.

27 May 2024 in Journal of Ayurveda and Integrative Medicine
Verified
Journal Article
Open access
STSaketh Ram Thrigulla
Saketh Ram Thrigulla
GSGagandeep Singh
Gagandeep Singh
HSHemant Soni
Hemant Soni
STSmriti Tandon
Smriti Tandon
SKShruti Koulgi
Shruti Koulgi
RARabinarayan Acharya
Rabinarayan Acharya
Shyonaka (Oroxylum indicum Vent) is widely used in Ayurveda and in ethnomedical practice for the treatment of inflammation, pain, diarrhea, non-healing ulcers, and cancer. Owing to the high prevalence of Epstein-Barr virus (EBV) infection in Nasopharyngeal carcinoma (NPC) patients, simultaneous targeting of proteins involved in both EBV replication and NPC proliferation might help to manage the disease effectively. This study is designed to identify potential dual targeting inhibitors from Oroxylum indicum having the potential to inhibit both EBV and NPC. This study also attempted quantitative analysis of Shyonaka Bark Decoction (SBD) to confirm the presence of Baicalein and Chrysin which are predominant marker compounds of Shyonaka. The HPLC analysis of stem bark and root bark of Oroxylum indicum was done to estimate the presence of marker compounds Baicalein and Chrysalin. The in-silico analysis included ADMET analysis followed by molecular docking of known compounds from Oroxylum indicum (retrieved from IMPPAT database) onto the target proteins of EBV (BHRF1, NEC1, dUTPase, Uracil DNA glycosylase) and NPC (COX-2, EGFR, and MDM2) using DOCK6 tool. Further validations were done using the molecular dynamics simulations of top screened molecules onto the selected target proteins using AMBER20 package and their corresponding MMGBSA binding free-energy values were calculated. The molecular docking revealed that the key molecules from the plant, scutellarein 7-rutinoside (S7R), scutellarin (SCU) and 6-hydroxyluteolin, Baicalein and 5,7-Dihydroxy-2-phenyl-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one (57D) are effectively intervening with the target proteins of EBV, one of the key causative factors of NPC and the NPC specific targets which have the potential to reduce tumor size and other consequences of NPC. The molecular dynamics simulations of S7R, Baicalein and 57D, Baicalein with MDM-2 protein and dUTPase protein, respectively, showed stable interactions between them which were further assessed by the binding energy calculations. Overall, the in-silico evaluation of these phytochemicals with target proteins indicates their potential to inhibit both EBV and NPC which needs further in-vitro and in-vivo validations.

9 October 2025 in In Silico Research in Biomedicine
Verified
Journal Article
Open access
GSGagandeep Singh
Gagandeep Singh
NPNitika Patwa
Nitika Patwa
HSHemant Soni
Hemant Soni
STSmriti Tandon
Smriti Tandon
VGVandana Gupta
Vandana Gupta

1 June 2025 in Current Probiotics
Verified
Journal Article
Closed access
PDF file
PBPrateeksha Bhagwat
Prateeksha Bhagwat
HSHemant Soni
Hemant Soni
STSmriti Tandon
Smriti Tandon
GSGagandeep Singh
Gagandeep Singh
SLSanjeev Kumar Lale
Sanjeev Kumar Lale
RARabinarayan Acharya
Rabinarayan Acharya
The definition and comprehension of prebiotics have undergone a substantial transformation over the years, culminating in a consensus in 2016 among an expert panel from the International Scientist Association for Probiotics and Prebiotics (ISAPP). This revision suggests that prebiotics are substances that promote the growth of probiotics, thereby benefitting the health of the host. These substances are no longer restricted to dietary carbohydrates and have expanded to include bioactive compounds such as polyphenols. The objective of this review is to offer a thorough examination of carbohydrate-based prebiotics (e.g., FOS, GOS, Inulin), their natural modulation, herbal interventions, microbial-based substances, and their influence on gut health. Additionally, it will investigate their association with the Indian traditional medicinal system. A review was conducted to identify and analyze studies related to prebiotics, including their categories, commercial availability, and applications. The investigation was expanded to encompass the interactions between the intestinal microbiome, diet, epigenetics, and the mechanism of action of prebiotics. The relationship between prebiotics and the Indian traditional medicinal system, emergent dietary inventions, and microbial products such as synbiotics, postbiotics, and para-probiotics that have demonstrated potential in gut health management with minimal side effects were all given special attention. The review emphasizes novel discoveries, including the integration of a variety of dietary interventions and microbial products into digestive health management, as well as the role of bioactive compounds (e.g., polyphenols) as potential prebiotics. Additionally, the review emphasizes the potential synergistic benefits and compatibility of integrating contemporary prebiotic research with practices from the Ayurvedic medicinal system. The increased understanding of prebiotics, which extends beyond dietary carbohydrates to encompass a variety of bioactive compounds, creates new opportunities for research and implementation in the management of integrative gut health. This review has identified herbal interventions and microbial products as promising frontiers for future research. The integration of these discoveries into therapeutic interventions and consumer products has the potential to significantly increase health outcomes with minimal side effects, thereby representing a significant advancement in the field of gut health research.

30 December 2017
Verified
Book Chapter
Closed access
PDF file
HRHemant Kumar Rawat
Hemant Kumar Rawat
HSHemant Soni
Hemant Soni
NKnaveen kango
naveen kango

1 May 2024 in Journal of Drug Research in Ayurvedic Sciences
Verified
Journal Article
Open access
GSGagandeep Singh
Gagandeep Singh
APAkanksha Singh Parihar
Akanksha Singh Parihar
VSVishakha Sharma
Vishakha Sharma
STSmriti Tandon
Smriti Tandon
PBPrateeksha Bhagwat
Prateeksha Bhagwat
RARabinarayan Acharya
Rabinarayan Acharya
BACKGROUND: Serratia marcescens is a well-known Gram-negative, rod-shaped bacterium commonly found in soil, animal skin, hospital environment, and plant-based raw materials. It is an opportunistic pathogen that causes serious infections, including pneumonia, bloodstream infection, wound infection, meningitis, and respiratory and urinary tract infections. Due to multiple resistant strains of S. marcescens being identified, new and effective plant-based antimicrobial compounds/drugs against S. marcescens must be searched. The present study is focused to explore the Stem of Neem (Azadirachta indica), Seed of Nirgundi (Vitex negundo) and Clove buds (Syzygium aromaticum) for their antibacterial activity against the isolated S. marcescens. METHODS: The S. marcescens was isolated from the garden soil of CARI Jhansi and identified based on various morphological and biochemical tests. We also checked the antibiotic profile of isolated S. marcescens. The ethanolic and methanolic extracts of the selected plant parts were prepared and explored for their antibacterial activity against S. marcescens using the disc diffusion method. RESULTS: The antibiotic profile of S. marcescens showed resistance to multiple broad-spectrum antibiotics, including erythromycin, rifampicin, chloramphenicol, and narrow-spectrum antibiotic vancomycin. At the same time, it was sensitive to kanamycin, streptomycin, ciprofloxacin, and ofloxacin. We observed that both methanolic and ethanolic extracts of clove buds were effective, while only the ethanolic extract of Nirgundi seed and Neem stem were found to be effective against S. marcescens. CONCLUSION: From this study, we conclude that both methanolic and ethanolic extracts of Clove buds, while only the ethanolic extract of Nirgundi seed and Neem stem, were found effective and showed significant inhibition of growth of S. marcescens.